title: Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation.
abstract: A main issue in controlled delivery of biotechnological products from injectable biodegradable microspheres is to preserve their integrity and functional activity after the microencapsulation process and final sterilization. The present experimental work tested different technological approaches to maintain the biological activity of an encapsulated biotechnological product within PLGA [poly (lactic-co-glycolic acid)] microspheres (MS) after their sterilization by gamma irradiation. GDNF (glial cell line-derived neurotrophic factor), useful in the treatment of several neurodegenerative diseases, was chosen as a labile model protein. In the particular case of optic nerve degeneration, GDNF has been demonstrated to improve the damaged retinal ganglion cells (RGC) survival. GDNF was encapsulated in its molecular state by the water-in-oil-in-water (W/O/W) technique or as solid according to the solid-in-oil-in-water (S/O/W) method. Based on the S/O/W technique, GDNF was included in the PLGA microspheres alone (S/O/W 1) or in combination with an antioxidant (vitamin E, Vit E) (S/O/W 2). Microspheres were sterilized by gamma-irradiation (dose of 25 kGy) at room and low (-78 °C) temperatures. Functional activity of GDNF released from the different microspheres was evaluated both before and after sterilization in their potential target cells (retinal cells). Although none of the systems proposed achieved with the goal of totally retain the structural stability of the GDNF-dimer, the protein released from the S/O/W 2 microspheres was clearly the most biologically active, showing significantly less retinal cell death than that released from either W/O/W or S/O/W 1 particles, even in low amounts of the neurotrophic factor. According to the results presented in this work, the biological activity of biotechnological products after microencapsulation and sterilization can be further preserved by the inclusion of the active molecule in its solid state in combination with antioxidants and using low temperature (-78 °C) during gamma irradiation exposure.
authors: Dep. of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Avd. Complutense s/n, Complutense University, Madrid 28040, Spain.
authors: P
authors: P
authors: Checa-Casalengua
authors: C
authors: C
authors: Jiang
authors: I
authors: I
authors: Bravo-Osuna
authors: B A
authors: BA
authors: Tucker
authors: I T
authors: IT
authors: Molina-Martínez
authors: M J
authors: MJ
authors: Young
authors: R
authors: R
authors: Herrero-Vanrell
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000737:chemistry* / Q000528:radiation effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry* / Q000528:radiation effects; D004339:Drug Compounding; D005720:Gamma Rays; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000008:administration & dosage / Q000737:chemistry* / Q000528:radiation effects; D019344:Lactic Acid / Q000008:administration & dosage / Q000737:chemistry* / Q000528:radiation effects; D051379:Mice; D008863:Microspheres; D011100:Polyglycolic Acid / Q000008:administration & dosage / Q000737:chemistry* / Q000528:radiation effects; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000737:chemistry / Q000528:radiation effects; D012160:Retina / Q000166:cytology; D013242:Sterilization; D013696:Temperature; D014810:Vitamin E / Q000008:administration & dosage / Q000737:chemistry* / Q000528:radiation effects
chemical_list: D000975:Antioxidants; D004337:Drug Carriers; D051100:Glial Cell Line-Derived Neurotrophic Factor; D011994:Recombinant Proteins; D014810:Vitamin E; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid